Home/ Stocks/ CNTA

Centessa Pharmaceuticals plc American Depositary Shares

CNTA XNAS

$27.89 +2.34 (+9.02%) ▲ 15-min delayed

Open

$25.73

High

$27.96

Low

$25.17

Volume

2.27M

Market Cap

$3.83B

About Centessa Pharmaceuticals plc American Depositary Shares

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 114 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$0	$-54,891,000	$-0.41
Q2 2025	$0	$-50,343,000	$-0.38
Q1 2025	$15.00M	$-26,135,000	$-0.20
FY 2024	$0	$-235,757,000	$-2.06

Earnings & Analyst Ratings

Next Earnings: Tue, May 12, 2026

Calendar →

Related Market News

No specific coverage for CNTA yet. Check out our latest market news or earnings calendar.

Get CNTA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Centessa Pharmaceuticals plc American Depositary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.